News stories about Ultralife (NASDAQ:ULBI) have been trending somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Ultralife earned a news sentiment score of 0.05 on Accern’s scale. Accern also assigned news articles about the technology company an impact score of 47.3717568729337 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Shares of Ultralife (ULBI) opened at $7.05 on Tuesday. Ultralife has a 52 week low of $5.05 and a 52 week high of $7.90. The stock has a market cap of $111.14, a price-to-earnings ratio of 19.19 and a beta of -0.11.
Ultralife (NASDAQ:ULBI) last released its quarterly earnings data on Thursday, February 8th. The technology company reported $0.12 earnings per share for the quarter. The company had revenue of $22.51 million for the quarter. Ultralife had a net margin of 8.94% and a return on equity of 7.74%.
TRADEMARK VIOLATION NOTICE: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/13/ultralife-ulbi-earns-daily-coverage-optimism-rating-of-0-05.html.
Ultralife Corporation offers products and services ranging from power solutions to communications and electronics systems. The Company designs and manufactures power and communications systems, including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom engineered systems.
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.